As the Centers of Medicare & Medicaid Services continues to increase reviews to ensure hospice agencies remain compliant, it is crucial to ensure your are properly managing Additional Development Requests and appeals. Discover current process trends, best practices to follow, and how effective teamwork can lead to long-term success.
Assisted living communities that operate with a high level of quality care give families the confident and comfort they need in knowing their loved ones are in a safe place. Defining your community's key risks areas and creating an efficient improvement plan is crucial to ensuring quality of care is top of mind.
Due to the COVID-19 Public Health Emergency (PHE), CMS has waived the Home Health Condition of Participation under 42 CFR § 484.55(a) regarding the initial assessment. Learn the difference between the initial visit vs. a SOC Comprehensive Assessment.
Review Choice Demonstration is in full cycle in Illinois, Ohio, North Carolina, Florida, and Texas. In June 2021, Palmetto GBA posted the top reasons for non-Affirmation and claim denials, many being related to Face-to-Face encounters.
After the delay of the OASIS-E implementation due to the ongoing COVID-19 Public Health Emergency, CMS has announced that it is projected to be put into effect at the start of 2023. Organizations need to understand the scope and comprehensiveness of these changes.
Developing, reassessing, and documenting toward therapy goals and current function are essential building blocks toward a necessary and comprehensive therapy care plan. Learn how to enhance your compliance.
Review Choice Demonstration (RCD) has officially rolled out across five states (Ohio, Illinois, Texas, North Carolina and Florida). It is critical that home health organizations fully understand the requirements and recognize the impacts the demonstration has on the industry.